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Abstract 
Background: To analyze the characteristics of 
skeletal and extra skeletal Ewing’s sarcoma / 
Primitive Neuroectodermal Tumors PNET .  
Methods:  In this descriptive cross-sectional study 
cases of skeletal and extra skeletal PNET were 
analyzed. Age, gender, site of biopsy, and results of 
Immunohistochemistry were recorded.  
Results: Out of 80 cases, 65.4 % were males . The 
age ranged from 1 to 45 years, with the mean age of 
18 years. Most frequent age group was the second 
decade of life(54 %). There were 37 cases of Skeletal 
Ewing Sarcoma and 43 cases of Extra skeletal PNET. 
Among the 37 ( 47 % ) cases of Ewing sarcoma of 
bone, femur (21.62%) was the commonest. Out of the 
43 cases of Extra skeletal PNET, 41 had peripheral 
PNET while 2 had CNS PNET. In the 41 patients of 
Primitive PNET, head and neck (18.6%) and chest 
(Askin Tumor) (16.27%) were the commonest. CD 99 
was positive in 73 %, while, NSE, and Cytokeratin 
were positive in 32%. Periodic Acid Schiff was 
positive in 53 cases. 
Conclusion: Extra skeletal (53.75%) involvement 
comprises a larger number of cases as compared to 
skeletal Ewing’s sarcoma. Majority of the cases 
present in the second decade of life. In skeletal 
Ewing’s Sarcoma, femur is the commonest involved 
site. Head and neck and chest are the commonest in 
extraskeletal. In extraskeletal a propensity of the soft 
tissue around leg is also observed   
Key Words: CD 99, Bone tumour, Ewing sarcoma, 
Femur, PNET. 
 
Introduction 
     Ewing sarcoma and the peripheral primitive 
neuroectodermal tumour are found to contain the 
same reciprocal translocation between chromosomes 
11 and 22, t (11; 22). Both the entities are now included 
in a bigger category called the “Ewing family of 
Tumors”. When the tumour involved the skeletal 
system it was called “Ewing sarcoma” and when there 
was extra skeletal involvement then the term primitive 
neuroectodermal tumour was used. Current evidence 
indicates that both Ewing's sarcoma and PNET have a 
similar neural phenotype, similar histological 
appearance and, as they share an identical 
chromosome translocation, they should be viewed as 
the same tumour, differing only in their degree of 
neural differentiation.1Approximately 80% of patients 
present with localized disease. The incidence in whites 
is at least 9 times higher than that in blacks.  A local 
study carried out in Karachi, reported 4.7 % cases of 
Ewings sarcoma among malignant tumours.2 
     There are various classifications of the Ewing family 
of tumors. Batsakis et al in 1996 divided the primitive 
neuroectodermal tumor (PNET) family of tumours 
into  3 groups based on the tissue of origin: CNS 
primitive neuroectodermal tumors (PNET's), 
Neuroblastoma and Peripheral primitive 
neuroectodermal tumors (pPNETs).3 The Ewing family 
of tumors includes Ewing tumor of bone, extraosseous 
Ewing tumours,primitive neuroectodermal tumors 
(PNET ) and Askin tumors (PNET of chest wall ). 
Histologically all these tumors have the same 
morphology with littler variation depending upon the 
extent of differentiation. The term primitive 
neuroectodermal tumours (PNET's) and Ewings 
sarcoma are now used interchangeably in the 
literature.  
     Immunohistochemical analyses have helped 
distinguish PNET's and Ewing family of tumors (EFTs) 
from other small, round, blue cell tumors, such as 
rhabdomyosarcoma, neuroblastoma, and lymphoma. 
CD 99 an immuno marker which functions as a cell 
surface glycoprotein with differentiation of primitive 
neuroectodermal cells show constant cell membrane 
staining pattern in Ewing / PNET. Special stain for 
periodic acid Schiff (PAS) detects the presence of 
glycogen in the tumor cells.4  
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Patients and Methods  
     This study was carried out in the Department of 
Histopathology, Armed Forces Institute of 
Pathology,Rawalpindi from January 2009 to December 
2010. Gross examination of surgical specimens was 
performed and the material was processed under 
standardized conditions for paraffin embedding. The 
sections were stained with Hematoxylin and eosin 
(H/E). Immunohistochemistry panel was applied for 
confirmation of the H/E diagnosis.  
 
Results  
    Among the total of 81 cases,65.4 % were males with 
a male to female ratio of 1.8:1 The age ranged from 1 to 
45 years, with the mean age of 18 years. Most frequent 
age group was the second decade of life with (54 %), 
followed by 21 % cases in the third decade, 17.3% in 
the first decade. Cases were divided into Primary 
Ewing Sarcoma of the bone and PNET. PNET was 
further divided into peripheral PNET and CNS PNET. 
Among the 37 (47 %) cases of Ewing sarcoma of bone, 
8 (21 %) had a tumor arising from the femur(Table 1).  
 
 
Figure 1: :A: Gross photograph of Ewing sarcoma of Tibia. 
B: Tissue section of Ewing sarcoma showing sheets of 
small round blue cell with indistinct cytoplasm and 
prominent nucleoli. (Hematoxylin and Eosin, x 400).C: 
Periodic acid Schiff stain showing positivity for glycogen 
in the cytoplasm of the cells. (PAS stain, x 400). 
 
Among the 43 patients of PNET, 41 patients had 
peripheral PNET. Out of which 18.6% had a tumour 
arising in the head and neck region. Seven (16.27%) 
had a tumor arising in the chest region (Askin Tumor)  
 (Table 2). There were only 2 (2.4 %) cases of CNS 
PNET. Immunohistochemical marker CD 99 was 
positive in 73%. While, NSE, and Cytokeratin were 
positive in 32%, respectively. Special stain for Periodic 
Acid Schiff was positive in 53 % (Figure 1). 
Table 1:- Site of involvement in Skeletal 
Ewing’s sarcoma / PNET(n=37) 
Site of involvement No(%)  
Femur 8(21.62) 
Spine 7(18.91) 
Scapula 4(10.81) 
Proximal tibia 4(10.81 
Iliac crest 2(5.4) 
Sacrum  2(5.4) 
Pelvis 2(5.4) 
Fibula  1(2.7) 
Ankle 1(2.7) 
Humerus  1(2.7) 
Knee 1(2.7) 
Iliac bone 1(2.7) 
Distal radius 1(2.7) 
Proximal tibia 1(2.7) 
Coccyx  1(2.7) 
 
Table- 2:- Site of involvement of Extra Skeletal 
Ewing’s sarcoma / PNET(n=43) 
Site of involvement Number of cases  
Head and Neck 8(18.6) 
Chest region 7(16.27) 
Proximal arm 3(6.9) 
Kidney 3(6.9) 
Forearm 2(4.6) 
Big toe 2(4.6) 
Gluteal region 2(4.6) 
Inguinal region 2(4.6) 
Abdomen 2(4.6) 
Leg 2(4.6) 
Axilla 2(4.6) 
Costovertebral triangle 2(4.6) 
Foot 2(4.6) 
Paraspinal region 2(4.6) 
CNS PNET 2(4.6) 
 
Discussion 
     Ewing’s sarcoma is an intriguing entity that can 
involve the skeletal system and the soft tissues of the 
body. Ewing sarcoma and the peripheral primitive 
neuroectodermal tumours both show the same 
reciprocal translocation between chromosomes 11 and 
22, t(11;22). In the United States the annual incidence 
of Ewing sarcoma family tumors from birth to age 20 
years is 2.9 cases per million population. 6-8  
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    Data of present study showed a larger number of 
extra osseous Ewing’s sarcoma(53.75%) as compared 
to primary bone Ewing’s sarcoma. These results are in 
contrast with what is reported in the literature. Femur 
is  the most commonly affected bone.9  Xie and 
colleagues described 18 patients, with extra osseous 
Ewings sarcoma. Among these cases 8 (44.4%) patients 
had tumors originated from lower extremities, 5 
patients (27.8%) from paravertebral region, 2 (11.1%) 
from chest wall, and the rest involved the upper limb, 
pelvic and submandibular area each (5.6%).10  
     Head and neck region is  the most common  site of 
involvement of extra osseous Ewing’s sarcoma.11,12 
Our data showed seven cases of Extra osseous Ewing’s 
arising in the chest wall. Askin et al first reported these 
tumors located in the thoracopulmonary region. 
Shamberger and Gries reported a series of 73 
malignant chest wall tumors, among which 56 % cases 
were of Ewing’s sarcoma.13,14    
     CNS Extra osseous Ewing’s sarcoma may be 
confused histologically with c-PNET such as 
medulloblastoma. The supratentorial location and 
positivity for CD 99 immunomarker helps to resolve 
the dilemma. In problematic cases, translocation 
t(11;22) (q24;q12) should be demonstrated. In present 
series there were two cases of CNS Extra osseous 
Ewing’s sarcoma. Both the cases were located in the 
supratentorium and showed CD 99 positivity.  
     The Ewing’s family of tumors is characterized by 
increased expression of MIC2/CD99. CD99,a cell 
surface glycoprotein,plays a role in the differentiation 
of primitive neuroectodermal cells and T cell apoptosis 
and adhesion.15  It is diffusely expressed in nearly all 
cases of ES/PNET (>95%) with a cell-membranous 
pattern positivity.  In present study 90 % of the cases 
were positive for CD 99/MIC2 and in the remaining 10 
% of the cases, the diagnosis of Ewing’s sarcoma / 
PNET was suggested on the basis of the positivity for 
special stain PAS ( Periodic acid Schiff ) and negativity 
for LCA, desmin, myogenin, osteopontin, osteonectin. 
PAS special stain was positive in 55 % of the cases. 
Initially CD99 was thought to be a highly specific 
immunomarker for Ewing / PNET but recent studies 
have shown its positivity in variety of other tumors 
such as lymphoblastic lymphoma and some cases of 
alveolar rhabdomyosarcoma.16 Vimentin, CD 57, NSE 
(Neuron specific enolase), synaptophysin and 
cytokeratin have all shown to be positive in Ewing’s 
sarcoma/PNET. In our study cytokeratin and NSE 
were positive in 40 % of the cases respectively. 
Recently a new immunomarker FLI1 (Friend leukemia 
integration 1 transcription factor),a member of the ETS 
transcription factor family has shown promising 
results.  
Conclusions 
1.CD 99 together with special stain PAS are sufficient 
in majority of the cases to make a final diagnosis.  
2.Clinical history, radiological  findings, site, 
microscopic findings and immunohistochemical 
correlations are important in making diagnosis and  
predicting prognosis    
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